Supporting Patients Starting New Medicines: Evaluating the myCare Start Service in Switzerland

In Phase B, the aim is to evaluate the myCare Start service in routine care within the ambulatory primary care medicine and community pharmacy setting in Switzerland. A Type II hybrid effectiveness-implementation study will be conducted to evaluate the effectiveness (improvement in adherence), cost-effectiveness and implementation of the service. This evaluation will allow us to build the necessary contextual relevant evidence base to support sustainable funding of the service in the long term.

NCT Number	NCT07036471
Lead Sponsor	University of Geneva, Switzerland Collaborators: University of Basel, pharmaSuisse, Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland, University of Bern
Conditions	Cardio-vascular Disease, Depression Disorders, Diabetes, COPD, Asthma Bronchiale, Hyperlipidaemia, Medication Initiation for Long-term Conditions
Enrollment	1,600 participants
Start Date	2025-06
Primary Completion	2027-01 (estimated)
Study Completion	2027-01 (estimated)
Updated on ClinicalTrials.gov	2025-06-25